The publication of the ASCOT and Lindholm studies last year led many physicians to believe
that the era of beta-blockers for hypertension was over. Updated guidelines from the National
Institute for Health and Clinical Excellence and the British Hypertension Society are expected
later this year and should help to clear up any confusion. In this article, Dr Ahmet Fuat
discusses the future of beta-blockers in the management of hypertension in the elderly.